Takeda Pharmaceutical Company Limited
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
Last updated:
Abstract:
The present invention provides compounds of formula I: ##STR00001## which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
Status:
Grant
Type:
Utility
Filling date:
7 Aug 2018
Issue date:
11 Aug 2020